Stage III Multiple Myeloma: 437 Clinical Trials, Page 2 of 44

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Condition(s):Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:March 1, 2021Completed

Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

Condition(s):Multiple Myeloma in Relapse; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 1, 2017Completed

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 19, 2018Completed

Arsenic Trioxide in Treating Patients With Multiple Myeloma

Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 6, 2020Terminated

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:July 2, 2019Completed

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Condition(s):Mucositis; Multiple MyelomaLast Updated:April 15, 2014Completed

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:May 31, 2013Completed

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:June 26, 2013Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma

Condition(s):Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell NeoplasmLast Updated:June 20, 2013Completed

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Condition(s):Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:August 21, 2015Completed

«1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.